Skip to content

Clinical study on the therapeutic effect of thermosensitive canisters on the recovery of gastrointestinal function after colorectal cancer surgery

Clinical study on the therapeutic effect of thermosensitive canisters on the recovery of gastrointestinal function after colorectal cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001968
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-07-10
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

control group:Referring to the Shanghai Expert Consensus on Integrated Traditional Chinese and Western Medicine in Enhanced Recovery After Surgery and the Clinical Practice Guidelines for Enhanced Rec
Thermal sensitive tank group:On the basis of the control group, thermosensitive cupping therapy was administered by selecting the Foot-Yangming Stomach Meridian on both lower limbs (Zusanli, Shangjuxu

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients who have undergone laparoscopic colorectal cancer resection; 2) Age: 18 years old to 80 years old, gender not limited; 3) The type of surgical anesthesia was general anesthesia and met the classification criteria of American Society of Anesthesiologists (I-III). 4) Those with clear consciousness, high comprehension ability and the ability to express themselves clearly and completely; 5) The patient gave informed consent and voluntarily participated in this study; 6) Those who have not participated in other research projects. Only when all conditions are met simultaneously can they be included in this study.

Exclusion criteria

Exclusion criteria: Patients with any of the following conditions will be excluded from the study: 1. Those with organic lesions in important organs such as the heart, liver, lungs, and kidneys or mental disorders; 2. Those undergoing palliative or emergency surgery; 3. Those requiring combined resection of other organs; 4. Those experiencing severe complications during surgery (such as anastomotic leakage or gastrointestinal bleeding); 5. Those with a history of abdominal surgery; 6. Those who failed laparoscopic surgery and had to switch to open surgery; 7. Those with skin damage, allergies, redness, or swelling at the moxibustion site; 8. Those with asthma, allergic rhinitis, or who cannot tolerate the smoke from moxa; 9. Those with consciousness disorders, sensory disorders, language disorders, hearing disorders, or diabetes; 10. Those undergoing hyperthermic intraperitoneal chemotherapy after surgery.

Design outcomes

Primary

MeasureTime frame
The time of the first defecation after surgery;

Secondary

MeasureTime frame
The time of the first flatus after surgery;The time of the first meal after the operation;Incidence of postoperative complications;laboratory index;Visual Analogue Scale (VAS);Quality of Recovery-40,QoR-40;hospital stays;Gastrointestinal Symptom Rating Scale;

Countries

China

Contacts

Public Contactchunjiao zhou

Guangdong Provincial Hospital of Traditional Chinese Medicine

gzchunjiao@163.com13533370691

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026